Six non-clonally related enterobacterial isolates producing a same extended-spectrum L-lactamase CTX-M-15 were isolated in 1999 from patients hospitalized in a New Delhi hospital. CTX-M-15 differed from CTX-M-3 by an asparagine to glycine substitution in position ABL238. Its gene was located on large plasmids varying in size. In each case, a same insertion sequence ISEcp1 was identified upstream of the 5P end of bla CTXÀMÀ15 . Typical 335 and 310 promoter sequences of Enterobacteriaceae were identified in the 3P end of ISEcp1. The location of ISEcp1 upstream of plasmid-mediated CTX-M-type L-lactamase genes may contribute to their spread or/and their expression. ß
Introduction
Several clavulanic acid-inhibited Ambler class A expanded-spectrum L-lactamases (ESBLs) have been reported mostly in Enterobacteriaceae in addition to the TEM-and SHV-type ESBLs. Among them, the CTX-Mtype L-lactamases are plasmid-mediated ESBLs and confer high level resistance to cefotaxime, ceftriaxone, aztreonam and have only marginal e¡ects on MIC of ceftazidime [1] .
The ¢rst CTX-M L-lactamase (CTX-M-1/MEN-1) was characterized in Escherichia coli strains isolated from German and Italian patients [2, 3] . This family of enzymes now comprises 12 members, CTX-M-1 to CTX-M-10, Toho-1 and Toho-2 [1^6]. These enzymes share 80^99% amino acid identity. E. coli and Salmonella enterica serotype typhimurium are the enterobacterial species most frequently reported to produce the CTX-M L-lactamases [1^7]. The CTX-M-type producing strains are endemic in Latin America, in Japan and in some areas in Eastern Europe [1, 4] . Rare reports signal the presence of CTX-M enzymes in enterobacterial isolates from other countries such as in Greece (Eastern Europe origin), Spain, Taiwan, and France [1,5^8] .
Although ESBLs have been reported worldwide, infrequent reports have characterized such enzymes from Indian isolates [9^12] . SHV-type ESBLs have been isolated from Salmonella spp. and Shigella spp. in India [9, 10] and an unsequenced SAR-2 enzyme with a pI value of 8.6 has been reported from an E. coli isolate from South India [13] .
In this work, we have analyzed the L-lactamase content of several enterobacterial isolates from India that had an ESBL phenotype based on the positive results of a doubledisk synergy test. We discovered CTX-M-15 located on large size plasmids with and ISEcp1 sequence upstream of the 5P end of bla CTXÀMÀ15 .
Materials and methods

Bacterial strains and plasmids
Six enterobacterial strains (four E. coli, one Klebsiella pneumoniae, one Enterobacter aerogenes) were identi¢ed by the API 20-E system (bioMërieux, Marcy-L'Etoile, France). They were isolated from urinary and pulmonary human specimens from April to May 2000 at the Batra Hospital and Medical Research Centre in New Delhi.
Antimicrobial agents and susceptibility testing
Antibiotic-containing disks were used for antibiotic susceptibility testing by disk di¡usion assay (Sano¢-Diagnostics Pasteur, Marnes-la-Coquette, France), as described [14] . The double-disk synergy test was performed with ceftazidime^, cefotaxime^, aztreonam^and amoxicillinĉ lavulanic acid-containing disks on Mueller^Hinton (MH) agar plates without or with cloxacillin (250 mg l 31 ), in this latter case for detecting clavulanic acid-inhibited ESBLs in those strains that produced also AmpC-type enzymes [14] . MICs were determined by an agar dilution technique as described previously [14] .
Genetic techniques
Using the random ampli¢ed polymorphism DNA (RAPD) technique (ERIC-2 primer [14] ), the E. coli isolates were genotyped. Conjugation experiments were performed between the enterobacterial isolates and rifampinresistant E. coli C600 as recipient in solid and liquid media at 37³C, as described [14] . Transconjugants were selected on Trypticase soy (TS) agar plates containing rifampin (200 mg l 31 ) and cefotaxime (1 mg l 31 ). Plasmid DNA extractions of the enterobacterial isolates were performed as described previously and used for electroporation into E. coli DH10B electrocompetent strains selected onto cefotaxime-containing TS plates [14] . Plasmid DNAs from the enterobacterial isolates and their transformants were compared to those of reference sizes (E. coli NCTC 50192; 156, 66, 48, and 7 kb) [14] .
Plasmid DNAs were used as template in standard PCR experiments with sets of laboratory-designed primers for detection of class A L-lactamase genes and their extendedspectrum derivatives, bla TEM , bla SHV , bla PERÀ1a2 , bla VEBÀ1 , bla TohoÀ1a2 , bla GESÀ1 , bla CTXÀMÀ2 [14] , bla CTXÀMÀ3 (CTXM-A: 5P-CGCTTTGCGATGTGCAG-3P; CTXM-B: 5P-ACCGCGATATCGTTGGT-3P), and of other L-lactamase genes (bla OXAÀ1 , bla OXAÀ10 ) [14] . PCR experiments were also performed with primers hybridizing to the ends of the insertion sequences IS26 [15] and ISEcp1 (novel insertion sequence, ISEcp1, mobilizes the plasmid-mediated class C L-lactamase-coding gene, bla CMYÀ4 , Interscience Conference for Antimicrobial Agents and Chemotherapy, 1999, Stapleton, P.D., unpublished results and GenBank accession number AJ242809). IS26 and ISEcp1 had been found upstream of bla SHVÀ2a and of some plasmid-mediated cephalosporinase genes, respectively ( [15] and Stapleton, P.D.).
The PCR products were sequenced twice on both strands with an applied biosystems sequencer (model ABI 377) [14] .
IEF analysis
L-Lactamase extracts from cultures of the enterobacterial isolates and their E. coli transformants were obtained after sonication as described previously [14] . Analytical isoelectric focusing (IEF) analysis was performed on a pH 3.5^9.5 ampholine polyacrylamide gel, as described previously [14] . The pI values used as standards were those of SHV-1 (7.4), OXA-1 (7.6), CTX-M-3 (8.6), and TEM-1 (5.4).
Results and discussion
Strain characterization, plasmid transfer and analysis
RAPD analysis showed that the four E. coli isolates were not clonally related (data not shown). Direct transfer of the cefotaxime resistance marker failed except when E. aerogenes isolate was the donor. Using plasmid DNA extractions of the enterobacterial isolates, E. coli transformants were obtained in all cases. The plasmid sizes of these transformants ranged from ca. 145 to 155 kb (Table 1) .
Susceptibility testing and IEF analysis
Preliminary antibiotic susceptibility testing by disk diffusion showed synergy between ceftazidime-and clavulanate-containing disks for K. pneumoniae, E. aerogenes and two E. coli isolates (isolates 1 and 2). For E. coli isolates 3 and 4, a synergy was evidenced only on cloxacillin-containing MH plates. The enterobacterial isolates were resistant or have an intermediate susceptibility to amino-and ureidopenicillins, narrow-spectrum and oxyimino cephalosporins ( Table 2) . Addition of clavulanate and tazobactam signi¢cantly decreased the MIC values of oxyimino cephalosporins for the clinical isolates and E. coli transformants except for E. coli isolates 3 and 4. Since the E. coli transformants had a same clavulanic acid-inhibited oxyimino cephalosporin resistance pro¢le (Table 2) , an ESBL was likely present in all clinical isolates including E. coli isolates 3 and 4.
Antibiotic susceptibility testing by disk di¡usion showed that resistance to other antibiotic classes varied from a given clinical isolate or transformant to the other (Table  2) . Although the plasmids were of similar size, they likely varied in structure.
Extracts of cultures of E. coli 1 and 2 contained L-lactamases with pI values of 5.4, 7.6, and 8.6 and extracts of cultures of E. coli 3 and 4 gave an additional pI value of 8.2 (Table 1) (Table 1) . Four L-lactamases with pI values of 5.4, 7.4, 7.6, and 8.6 were identi¢ed from extract of K. pneumoniae culture while only one pI value of 8.6 was identi¢ed from culture extract of its transformant extract (Table 1) .
Characterization of L-lactamase genes
PCR ampli¢cations were positive for bla SHVÀ1 with K. pneumoniae and E. aerogenes isolates. This result was consistent with the pI value of 7.6 that corresponded to a naturally-occurring SHV-1-type enzyme in K. pneumoniae and to an acquired bla SHVÀ1 gene in E. aerogenes. PCR experiments were positive for bla TEMÀ1 , bla OXAÀ1 and bla CTXÀMÀ3 for all isolates and their transformants. These results corresponded to pI values of 5.4 for TEM-type, of 7.6 for OXA-1-type and of 8.6 for CTX-M-3-type enzymes. Sequence analyses identi¢ed the same narrow-spectrum TEM-1 and OXA-1 enzymes in all cases. The pI value of 8.2 of culture extract of E. coli 3 and 4 might have corresponded to an undetermined chromosomally or plasmid-encoded cephalosporinase (Tables 1 and 2 ).
Sequence analysis of the PCR products of bla CTXÀMÀ3 identi¢ed a bla CTXÀMÀ3 derivative, bla CTXÀMÀ15 , in all cases. CTX-M-15 di¡ered from CTX-M-3 by one amino acid substitution in position ABL238 (Asp to Gly). This enzyme conferred a higher level of resistance to ceftazidime than the other CTX-M-type enzymes ([1], Table 2 ). 
Genetic environment
From DNAs extracted from clinical isolates, a same insertion sequence ISEcp1 was identi¢ed in the 5P end of bla CTXÀMÀ15 . Sequence analysis did not ¢nd any promoter sequences upstream of the ATG start codon of bla CTXÀMÀ15 . However, typical 335 and 310 putative promoter regions corresponding to enterobacterial genes were identi¢ed within the 3P end of ISEcp1 (Fig. 1) . This insertion sequence may provide promoter regions that drive the expression of bla CTXÀMÀ15 . ISEcp1 had been identi¢ed upstream of the plasmid-mediated cephalosporinase gene bla CMYÀ4 from an E. coli isolate from the UK (Stapleton, P.D., GenBank accession number AJ242809) and parts of this sequence (30^60 bp) were identi¢ed upstream of the CTX-M-type genes bla TohoÀ1 and bla TohoÀ2 from Japan (Stapleton, P.D.).
The bla CMYÀ4 gene is related to the chromosome-encoded cephalosporinase from Citrobacter freundii (Stapleton, P.D.) and some CTX-M-type enzymes are closely related to the naturally-produced L-lactamases from the enterobacterial species Kluyvera ascorbata (GenBank accession number AJ251722) and Kluyvera cryocrescens (GenBank accession number AY026417, personal and unpublished data). Thus, ISEcp1 may be an e¤cient tool for mobilization and expression of L-lactamase genes, regardless of the origin of enterobacterial species, of the type of L-lactamase gene, and of the geographic origin of the isolated strains. The origin of ISEcp1 remains however to be determined. Association of ISEcp1 with L-lactamase genes which origin are enterobacterial species, may indicate that the donor of ISEcp1 is a bacterial species present in the gut. Finally, this report further underlines the worldwide spread of CTX-M-type ESBLs.
